Hudson Bay Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Hold |
0
| – | – | – | 639 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 644 |
|
2023
Q1 | – | Sell |
-20,731
| Closed | -$341K | – | 807 |
|
2022
Q4 | $341K | Buy |
+20,731
| New | +$341K | ﹤0.01% | 685 |
|
2020
Q3 | – | Sell |
-780,000
| Closed | -$8.35M | – | 520 |
|
2020
Q2 | $8.35M | Buy |
+780,000
| New | +$8.35M | 0.15% | 114 |
|
2019
Q2 | – | Sell |
-261,806
| Closed | -$759K | – | 371 |
|
2019
Q1 | $759K | Buy |
+261,806
| New | +$759K | 0.01% | 342 |
|
2018
Q4 | – | Sell |
-50,000
| Closed | -$220K | – | 446 |
|
2018
Q3 | $220K | Buy |
50,000
+6,917
| +16% | +$30.4K | ﹤0.01% | 415 |
|
2018
Q2 | $575K | Buy |
+43,083
| New | +$575K | 0.01% | 397 |
|
2018
Q1 | – | Sell |
-13,619
| Closed | -$813K | – | 447 |
|
2017
Q4 | $813K | Buy |
+13,619
| New | +$813K | 0.02% | 288 |
|
2017
Q1 | – | Sell |
-1,650
| Closed | -$1.61M | – | 405 |
|
2016
Q4 | $1.61M | Sell |
1,650
-3,422
| -67% | -$3.34M | 0.03% | 159 |
|
2016
Q3 | $4.41M | Sell |
5,072
-3,265
| -39% | -$2.84M | 0.11% | 62 |
|
2016
Q2 | $6.1M | Sell |
8,337
-2,108
| -20% | -$1.54M | 0.19% | 46 |
|
2016
Q1 | $5.92M | Buy |
10,445
+2,641
| +34% | +$1.5M | 0.28% | 39 |
|
2015
Q4 | $4.45M | Sell |
7,804
-2,420
| -24% | -$1.38M | 0.25% | 59 |
|
2015
Q3 | $4.08M | Sell |
10,224
-2,143
| -17% | -$855K | 0.18% | 68 |
|
2015
Q2 | $6.68M | Buy |
12,367
+4,306
| +53% | +$2.33M | 0.2% | 66 |
|
2015
Q1 | $3.94M | Buy |
8,061
+7,519
| +1,387% | +$3.68M | 0.1% | 80 |
|
2014
Q4 | $294K | Hold |
542
| – | – | 0.01% | 112 |
|
2014
Q3 | $289K | Buy |
+542
| New | +$289K | 0.01% | 153 |
|